NanoBlood LLC is dedicated to the development of a nano red blood cell (nRBC) from outdated banked blood and from donor bovine blood to meet the US and  global transfusion and therapeutic needs.



NanoBlood LLC is a nanomedicine company developing an innovative nanoparticle, VitalHemeTM, (click here for our US patent view ), as a nRBC with multiple therapeutic activities.  NanoBlood LLC is developing this multifunctional nRBC as a life saving therapeutic for meeting the need to correct insufficient blood flow and oxygen supply in critical care patients and those in need of blood transfusion. This nRBC represents a major breakthrough after half of a century of failed efforts to develop a safe alternative to RBC transfusion and is a multifunctional neurovascular protective therapeutic for the prevention and treatment of ischemia, reperfusion and inflammatory injuries.